I think if they do go with Capricor it would also be a very good thing for ANP.
Two drugs with questional abilities to treat DMD combined, could help open a larger market share for ANP. This is if previous results can be replicated for the ANP drug.
So much to look forward to. A maccas outing. Taking itsas Lambo for a blat. Watching Davo and Rochem see if their Rovers can really climb walls. All while mephistophles stops the boys from fighting over the maccas apple pie.
Bring it on.
Where others have failed will Atl1102 succeed ?, page-800
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.6¢ | $148.9K | 1.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48919 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 15.59pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.000 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 43057 | ||
| Last updated 13.04pm 03/05/2024 ? | |||||
| PER (ASX) Chart |